|
|
|
By GlobalData | Each month, Outsourced Pharma works in conjunction with PharmSource, part of GlobalData, to present its “Contract Manufacturing: Opportunities and Threats (CMOT) Report” to our readers. The report identifies CDMOs that might be impacted by key events affecting their clients, including company acquisitions, product acquisitions and licenses, product approvals, late clinical product terminations, and FDA rejections. | |
|
|
|
| Yeast Extracts: Improving Expression | Application Note | Nu-Tek Biosciences | Yeast extract improves E. coli protein production by over 50%, boosts desired protein attributes 4X, and offers a secure animal-free nutrient source. |
|
|
|
|
| Hunting An Unexpected mAb Variant With LC‑MS | Case Study | By Ben Zigterman, KBI Biopharma | A tailored LC–MS approach enables sensitive detection and tracking of monoclonal antibody variants, supporting deeper product characterization and better control of quality‑impacting changes. |
|
|
|
| Device Design For Usability And Risk Reduction | Article | By Dr. Sylvine Raverdy-Wilson, BD Medical - Pharmaceutical Systems | Growing use of large‑volume subcutaneous therapies is increasing demand for wearable injectors that reduce user error, simplify preparation, and enhance safety through human‑factors‑focused design. |
|
|
| From DNA To IND In As Little As 6 Months | Webinar | Lonza | Discover how an integrated, platform-driven CMC approach can accelerate your antibody program from DNA to IND in as little as six months while reducing risk and maintaining quality and regulatory alignment. |
|
|
|
|
|
|
|
|
|
|
|
| Connect With Bioprocess Online: |
|
|
|
